Ohio Administrative Code
Title 3701 - Department of Health - Administration and Director
Chapter 3701-55 - Newborn Screening for Genetic, Endocrine, or Metabolic Disorders
Section 3701-55-10 - Supplemental studies
Current through all regulations passed and filed through September 16, 2024
The director may conduct supplemental studies of the initial blood specimen collected pursuant to rule 3701-55-05 of the Administrative Code for the purpose of determining whether additional genetic, endocrine, or metabolic screening is necessary. The results of such supplemental studies will assist in determining whether additional screening can help detect other genetic, endocrine or metabolic disorders that cause disability if undiagnosed and untreated for which a medically accepted treatment is available. No additional blood samples or specimens will be required to conduct a supplemental study or screening.
(A) Each supplemental screening will be completed by the bureau of public health laboratory within seven business days after receiving the properly collected and submitted specimen.
(B) If upon supplemental screening of a specimen, the bureau of public health laboratory determines that a result indicates a potential risk for one or more of the supplemental screenings disorders, the director will communicate the results to the following person, as applicable:
